QA: Seelos Therapeutics INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2022_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 83,461,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 39,000
4 LiabilitiesCurrent 8,287,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 17,890,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,093,169
9 ResearchAndDevelopmentExpense 28,436,336
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -3,389,843
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 83,500,000
1 Liabilities 26,177,000
2 Expenses 46,529,505
3 Revenues 0
4 StockholdersEquity 57,323,000
5 NetIncome -49,919,348
6 ComprehensiveNetIncome -49,919,348
7 BaseVar 79,798,174
8 EconomicCapitalRatiobeforeLimitedLiability 1.37
9 EconomicCapitalRatio 2.58

Edgar->Model Mapping

Feature Distribution

Change over Time